Trimeris, Inc.

News and overview for Trimeris, Inc.

Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. [Press Release]
PRNewswire | 7 days 9 hours 33 minutes ago
...Enters Into Amendment To Merger Agreement With Trimeris, Inc. PRNewswire SEOUL, South Korea Nov. 17 SEOUL...announced merger agreement dated October 2, 2009 with Trimeris, Inc. ("Trimeris") . The amendment provides for an extension of...


Trimeris Announces Extension of Arigene Tender Offer and Amendment of Merger Agreement [Press Release]
Business Wire | 7 days 15 hours 38 minutes ago
Trimeris, Inc. (Nasdaq: TRMS) (“Trimeris”) today announced that it has agreed to an extension of the tender offer for all of Trimeris’ outstanding shares of common stock commenced by Arigene Co., Ltd. (“Arigene”) and RTM Acquisition Company (the “Purchaser”) on October 19, 2009 until 5:00 p.m., New York City time, on Monday, December 28, 2009. Based on a preliminary count by the depositary for the tender offer, as of the close of business on November 16, 2009, a total of 18,462,006 shares, wh...


Trimeris Reports Third Quarter 2009 FUZEON Sales Results [Press Release]
Business Wire | 41 days 9 hours 34 minutes ago
Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the third quarter of 2009 were $29.8 million, down 35 percent from $45.5 million in the third quarter of 2008, and up 2 percent from $29.1 million in the second quarter of 2009. Net sales of FUZEON in the U.S. and Canada for the third quarter of 2009 were $10.4 million, down 31 percent from $14.9 million in the third quarter of 2008, and up 7 percent from $9.7 million in the second quarter of 2009. Net sales of FU...


Arigene to purchase all outstanding shares of common stock of Trimeris
News-Medical.Net | 36 days 17 hours 48 minutes ago
Arigene Co., Ltd., a Korean corporation traded on the Korean Securities Dealers Association Quotation System (Arigene) (KOSDAQ: 067850), through its wholly-owned subsidiary, RTM Acquisition Company, a Delaware corporation, today commenced a cash tender offer to purchase all outstanding shares of common stock of Trimeris, Inc


Arigene Co., Ltd. Commences Tender Offer to Acquire All Outstanding Shares of Trimeris, Inc. Stock for $3.60 Per Share in Cash [Press Release]
Business Wire | 36 days 19 hours 5 minutes ago
Arigene Co., Ltd., a Korean corporation traded on the Korean Securities Dealers Association Quotation System (“Arigene”) (KOSDAQ: 067850), through its wholly-owned subsidiary, RTM Acquisition Company, a Delaware corporation, today commenced a cash tender offer to purchase all outstanding shares of common stock of Trimeris, Inc., a Delaware corporation (“Trimeris”) (NASDAQ: TRMS), pursuant to the Agreement and Plan of Merger among Arigene, RTM Acquisition Company and Trimeris, executed and pub...


Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of Trimeris, Inc. [Press Release]
Business Wire | 18 days 9 hours 56 minutes ago
Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Trimeris, Inc. (“Trimeris” or the “Company”) (Nasdaq: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by the Trimeris Board of Directors to sell all of the Company’s outstanding shares of common stock at a price of $3.60 per share to Arigene Co., Ltd. (“Arigene”).


Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Trimeris, Inc. - TRMS [Press Release]
Business Wire | 39 days 13 hours 44 minutes ago
Levi & Korsinsky is investigating the Board of Directors of Trimeris, Inc. (“Trimeris” or the “Company”) (NasdaqGM: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Arigene Co., Ltd. ("Arigene"). Under the terms of the agreement, Trimeris shareholders will receive $3.60 in cash for each share of Trimeris they own for a total transaction value of approximately of $81 million.


Law Office of Brodsky & Smith, LLC Announces Investigation on Behalf of Shareholders of Trimeris, Inc. [Press Release]
Business Wire | 39 days 7 hours 48 minutes ago
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Trimeris, Inc. (“Trimeris” or the “Company”) (Nasdaq:TRMS) relating to the proposed acquisition by Arigene Co., (“Arigene”). Arigene has agreed to acquire Trimeris in an all-cash deal valued at approximately $81 million.


Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Trimeris, Inc. [Press Release]
Business Wire | 36 days 9 hours 35 minutes ago
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Trimeris, Inc. ("Trimeris" or the "Company") (NASDAQ: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Arigene Co., Ltd. ("Arigene"). Under the terms of the agreement, Trimeris shareholders will receive $3.60 in cash for each share of Trimeris they own for a total transaction value of approxi...


Law Offices of Howard G. Smith Announces Class Action on Behalf of Shareholders of Trimeris, Inc. [Press Release]
Business Wire | 33 days 13 hours 20 minutes ago
Law Offices of Howard G. Smith announces that a class action has been filed in the Middle District of North Carolina against the board of directors of Trimeris, Inc. ("Trimeris" or the "Company") (NASDAQ: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Arigene Co., Ltd. ("Arigene"). Under the terms of the agreement, Trimeris shareholders will receive $3.60 in cash for each share of Trimeris they own for a ...


Trimeris profit sliced in half
American City Business Journals | 9 days 22 hours 48 minutes ago
A drop in sales and an increase in taxes drove down Trimeris Inc.


BRIEF-Arigene commences offer to acquire all outstanding shares of Trimeris
Forbes | 36 days 17 hours 38 minutes ago
Oct 19 (Reuters) - Trimeris Inc: * Arigene co., ltd. commences tender offer to acquire all outstanding shares of Article Controlsemail


BRIEF-Trimeris reports Q3 FUZEON sales results
Forbes | 41 days 8 hours 6 minutes ago
Oct 14 (Reuters) - Trimeris Inc: * Reports third quarter 2009 FUZEON sales results Article Controlsemail





 1  

13 Results

Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more

Company Overview


Company: Trimeris, Inc.
Industry: Biopharmaceuticals & Biotherapeutics
Website: http://www.trimeris.com

Trimeris safeguards cells from viral invaders. The company develops fusion inhibitor drugs that prevent viruses from attaching to a host cell. Its first product, Fuzeon, approved in the US and the European Union, can stop HIV from fusing with human cells in HIV patients for whom other antiretroviral therapies have failed. Development partner Roche markets Fuzeon worldwide. Trimeris is working to develop a next-generation fusion inhibitor drug that it hopes will prove more effective and require less frequent dosing than Fuzeon. After seeking strategic alternatives, the company has agreed to be acquired by Korean medical equipment firm Arigene.


Key Numbers

Sales in U.S. Dollars (mil.) 20.6 (2008)
One-year % Growth in Sales -58.3 (2008)
Net Income in U.S. Dollars (mil.) 8 (2008)
One-year % Growth in Net Income -70.8 (2008)
Number of Employees 4 (2008)
One-year % Growth in Number of Employees -55.6 (2008)
Fiscal Year-End December